HighLife raises €32M from Andera Partners, USVP and Sectoral Asset Management

HighLife, a medtech company developing a transcatheter mitral valve replacement system, raises €32M in a Series B co-led by USVP and Andera Partners, with Sectoral Asset Management, to fund clinical trials in Europe and the United States.